Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- EYE.AU
- Price
- 0.14
- Stock movement up
- +- (0.00%)
- Company name
- Nova EYE Medical Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 39.87M
- Ent value
- 42.36M
- Price/Sales
- 0.76
- Price/Book
- 2.10
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -12.63%
- 1 year return
- -9.68%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-12
DIVIDENDS
EYE.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.76 |
| Price to Book | 2.10 |
| EV to Sales | 0.81 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 284.82M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | -0.01 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.05M |
| Net receivables | 4.18M |
| Total current assets | 12.33M |
| Goodwill | 0.00 |
| Intangible assets | 6.86M |
| Property, plant and equipment | 10.04M |
| Total assets | 26.50M |
| Accounts payable | 2.35M |
| Short/Current long term debt | 3.02M |
| Total current liabilities | 5.15M |
| Total liabilities | 7.54M |
| Shareholder's equity | 18.97M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.14 |
| Daily high | 0.15 |
| Daily low | 0.14 |
| Daily Volume | 176K |
| All-time high | 1.59 |
| 1y analyst estimate | 0.39 |
| Beta | 0.72 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 21 Jul 2020 |
| Next earnings date | 24 Feb 2026 |
Downside potential
Loading...
Downside potential data
| EYE.AU | S&P500 | |
| Current price drop from All-time high | -91.19% | -1.08% |
| Highest price drop | -94.59% | -19.00% |
| Date of highest drop | 7 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -91.21% | -2.64% |
| Avg time to new high | - | 6 days |
| Max time to new high | 292 days | 89 days |
COMPANY DETAILS
Marketcap
39.87M
Marketcap category
Small-cap
Description
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma; iTrack Advance; and Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found